Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this pharmacokinetic study is to determine whether oral testosterone (T) ester
formulations can be used effectively to treat men with low testosterone.
Phase:
Phase 2
Details
Lead Sponsor:
Clarus Therapeutics, Inc.
Collaborators:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center